In this NBC Louisiana feature, Dotmatics’ VP of Science & Technology, Phil Mounteney, shared how artificial intelligence is transforming the future of drug discovery. While it typically takes up to ten years to bring a new drug to market, AI has the potential to cut that timeline in half—making the process faster, more affordable, and even revealing new applications for existing compounds.
“Think of drug discovery as finding needles in massive haystacks of data,” said Mounteney. “AI acts like a magnet, helping researchers surface insights far more efficiently than traditional methods.”
The interview also addresses public questions around data privacy and security in AI-driven healthcare. Dotmatics’ AI systems keep sensitive data securely in-house—never shared with public chatbots.
AI in life sciences is an exciting and sometimes controversial topic. Watch the full video to hear how Dotmatics is helping shape this important evolution in healthcare.
Learn More About Dotmatics
Schedule a meeting with our team to learn more about Luma's AI capabilities.